Price increases are the biggest driver of rising emergency room visit costs across the U.S., according to research led by the Center for Health and Biosciences' Vivian Ho and Sasathorn Tapaneeyakul.
Hospital at Home programs offer an alternative care model for acutely ill patients to receive intensive at-home treatment. With better policy and operations, can this model work at scale in the United States beyond the pandemic?
Anaeze C. Offodile II, Celynne Balatbat, Kushal T. Kadakia, Victor DzauAugust 23, 2021
The results of this study suggest that Medicare Data on Provider Practice and Specialty, which costs less to obtain than from a for-profit data source, can be used to reliably track the cost and quality effects of vertical integration between hospitals and physicians.
By Morgan N. Fredell, Hagop M. Kantarjian, Ya-Chen Shih, Vivian Ho and Binata Mukherjee
Current U.S. health care spending includes many areas of wasted expenditures. In this study, published in Cancer, the authors explore plans to optimize U.S. health care to provide greater benefits to patients: https://bit.ly/2TmeoDg
Every patient with cancer or another life-threatening disease wants the most effective treatment, but drug prices have become staggering. What determines the escalating prices of cancer drugs?
Donald Light, Hagop M. KantarjianSeptember 3, 2013
For both generic and patented cancer drugs, the free-market economy has not worked well. Solutions are needed to maintain reasonable drug prices that allow for corporate profits and are affordable to patients and to the U.S. health care system.
Hagop M. Kantarjian, Leonard A. ZwellingAugust 26, 2013
The emphasis is on the deterioration of the participation of the political institutions and politicians before the citizenry in Costa Rica, which shows a process of exhaustion, loss of legitimacy of institutions and actors. This process goes back a few decades and shows no sign, in the short term, of the emergence of new structures in the political system. This paper systematizes the morphology of exhaustion and identifies the trends in which the reform can be based. Such reform should be based on constitutional engineering and should support the political reform process from the tendencies of change that are expressed in the political system. Published in Revista Derecho Electoral, December 2013. In Spanish only.
In a genuine effort to protect patients from adverse events, regulatory burdens and research rigidity in clinical trials have increased to a point at which such protection is outweighing the benefits, and actually harming patients who are unable to be involved in clinical trials.
Hagop M. Kantarjian, David J. Stewart, Leonard A. ZwellingJune 6, 2013
Allowing the producer-dominated market to set drug prices has spiraled the cost of cancer drugs out of control. Drug pricing can be reduced while preserving the profit-making incentive, by linking price to a true measure of quality: preservation and meaningful prolongation of life.